Wearable Insulin Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Patches and Pods), By Age Group (Adults and Pediatrics), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Others), and By Region Forecast 2019-2030  

Wearable Insulin Devices Market size was valued at US$ 18.1 Billion in 2023 and is expected to grow at a CAGR of 10.2% from 2024 to 2030. Wearable insulin devices are medical devices that help in controlling or maintaining the blood glucose in the patient's body. Insulin is a major part of the treatment of diabetes. Insulin is the hormone made by the pancreas that allows the body to use or store the sugar or glucose from carbohydrates from food. It allows us to maintain the blood sugar level from either getting too high, which would result in hyperglycemia, or from getting too low which would result in hypoglycemia. Over the projection period, the widespread availability of  market such as insulin pens, syringes, pumps, and jet injectors will additionally boost demand for insulin delivery devices. Increased public awareness initiatives and campaigns regarding diabetes and its complications, long-term consequences, and treatment will drive demand for insulin-delivery devices. Obesity and diabetes are on the rise all over the world, which is fueling the market for insulin-delivery devices.

More significant aspects projected to have a positive impact on market growth include technological advancements in these devices, as well as increased patient knowledge regarding diabetes management. Insulin jet injections have no needles, whereas insulin pumps are comfortable to wear. Each device type has its own set of characteristics, but insulin pumps are expected to be a substantial income generator for the market. In the coming years, the market for insulin infuses pumps will be propelled by the launch of enhanced insulin delivery systems, such as portable insulin pumps.